| Literature DB >> 33791115 |
Aylin Güneşli1, Aynur Acıbuca2.
Abstract
AIM OF THE STUDY: The aim of this study was to evaluate the long-term effects of access to the femoral artery for the purposes of coronary angiography through the measurement of femoral artery distensibility and elasticity on the accessed and non-accessed sides.Entities:
Keywords: Doppler ultrasonography; coronary angiography; femoral artery
Year: 2021 PMID: 33791115 PMCID: PMC8008193 DOI: 10.15557/JoU.2021.0007
Source DB: PubMed Journal: J Ultrason ISSN: 2084-8404
Fig. 1.Measurement of maximum lumen and vessel diameter in systole (A), and minimum lumen and vessel diameter in diastole (B)
Baseline clinic, demographic and laboratory values of the study population
| Group 1 ( | Group 2 ( | Group 3 ( | Group 4 ( | ||
|---|---|---|---|---|---|
| Age [years] | 59.23 ± 5.62 | 60.7 ± 4.98 | 58.76 ± 5.66 | 59.61 ± 5.61 | 0.282 |
| Female sex [n (%)] | 23 (38.98) | 28 (49.12) | 21 (38.18) | 27 (45) | 0.598 |
| BMI [kg/m2] | 28.68 ± 3.56 | 28.73 ± 3.49 | 28.49 ± 3.18 | 28.71 ± 3.79 | 0.982 |
| Creatinine [mg/dL] | 0.78 ± 0.1 | 0.77 ± 0.11 | 0.79 ± 0.12 | 0.8 ± 0.13 | 0.577 |
| Hb [gr/dL] | 13.67 ± 1.29 | 13.76 ± 1.49 | 14.1±1.41 | 13.57 ± 1.41 | 0.2 |
| WBC [/mm3] | 7510 ± 1659 | 7212 ± 1923 | 7123 ± 1738 | 7309 ± 1887 | 0.614 |
| Platelets [100/mm3] | 280 (172) | 274 (56) | 245 (45) | 238 (81) | 0.075 |
| FPG [mg/dL] | 101.73 ± 9.87 | 102.16 ± 8.23 | 102.85 ± 10.26 | 102.53 ± 9.63 | 0.93 |
| HDL [mg/dL] | 45.47 ± 7.46 | 47.66 ± 9.05 | 47.36 ± 8.75 | 47.2 ± 6.97 | 0.457 |
| LDL [mg/dL] | 130.81 ± 16.35 | 135.1 ± 21.37 | 130.3 ± 16.73 | 132.21 ± 17.36 | 0.491 |
| Triglyceride [mg/dL] | 145 (88) | 134 (67) | 128 (79) | 147 (69) | 0.258 |
| EF [%] | 58.61 ± 2.91 | 58.78 ± 3.29 | 58.76 ± 2.97 | 59.08 ± 3.16 | 0.866 |
| SBP [mmHg] | 122.95 ± 6.8 | 124 ± 6.43 | 123.87 ± 9.12 | 122.82 ± 9.34 | 0.799 |
| DBP [mmHg] | 80.97 ± 5.45 | 81.04 ± 5.31 | 80.93 ± 5.83 | 81.60 ± 4.97 | 0.895 |
| USG time [month]* | 28 (16) | 29 (13.5) | 28 (14) | 27 (17.75) | 0.918 |
| SYNTAX Score | 7 (4) | 11 (6) | 15 (7) | 17 (5.75) | <0.001 |
| ASA [ | 33 (55.93) | 47 (82.45) | 48 (87.27) | 55 (91.66) | <0.001 |
| Beta blocker [ | 6 (10.16) | 27 (47.36) | 47 (85.45) | 55 (91.66) | <0.001 |
| Ca CB | 6 (10.16) | 6 (10.52) | 6 (10.9) | 5 (8.3) | 0.968 |
| Trimetazidine | 0 (0) | 0 (0) | 0 (0) | 12 (20) | NA |
| Nitrates [ | 0 (0) | 0 (0) | 11 (21.81) | 51 (85) | NA |
| Ranolazine | 0 (0) | 0 (0) | 6 (10.9) | 17 (28.33) | NA |
Comparison of femoral distensibility and elasticity between the sides with and without femoral access in different groups
| Group 1 ( | Group 2 ( | Group 3 ( | Group 4 ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Access side | No access side | Access side | No access side | Access side | No access side | Access side | No access side | |||||
| Distensibility [%] | 9.40 ± 0.84 | 9.48 ± 0.75 | 0.107 | 9.02 ± 0.81 | 9.23 ± 0.75 | <0.001 | 8.49 ± 0.77 | 9.18 ± 0.9 | <0.001 | 8.14 ± 0.74 | 9.03 ± 0.81 | <0.001 |
| Elasticity [%/mmHg] | 0.23 ± 0.03 | 0.23 ± 0.03 | 0.433 | 0.21 ± 0.02 | 0.22 ± 0.02 | <0.001 | 0.19 ± 0.02 | 0.21 ± 0.02 | <0.001 | 0.16 ± 0.01 | 0.2 ± 0.02 | <0.001 |